MASSAIA, Massimo Giovanni Stefano

MASSAIA, Massimo Giovanni Stefano  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 258 (tempo di esecuzione: 0.039 secondi).
Titolo Data di pubblicazione Autore(i) File
5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia. 1982 SYLWESTROWICZ TA; MA DDF; MURPHY P; M. MASSAIA; PRENTICE HG; HOFFBRAND AV; GREAVES MF
A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL 2007 Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M
A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma 2004 R. RIA; A. VACCA; F. RUSSO; T. CIRULLI; M. MASSAIA; P. TOSI; M. CAVO; D. GUIDOLIN; D. RIBATTI; F. DAMMACCO
ABCA1, apoA-I, and BTN3A1: A Legitimate ménage à trois in dendritic cells 2018 Riganti, Chiara; Castella, Barbara; Massaia, Massimo
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells 2011 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. 1988 DIANZANI U; PILERI A; BOCCADORO M; PALUMBO A; PIOPPO P; BIANCHI A; CAMPONI A; FOSSATI G; BATTAGLIO S; M. MASSAIA
Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies:correlation with diagnosis and disease status. 1988 Dianzani U; Pileri A; Boccadoro M; Palumbo A; Pioppo P; Bianchi A; Camponi A; Fossati G; Battaglio S; Massaia M
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase 2007 CURTI A; ALUIGI M; PANDOLFI S; FERRI E; ISIDORI A; SALVESTRINI V; DURELLI I; HORENSTEIN AL; FIORE F; MASSAIA M; PICCIOLI M; PILERI SA; ZAVATTO E; D'ADDIO A; BACCARANI M; LEMOLI RM
ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications 2022 Dainese, Cristina; Valeri, Federica; Pizzo, Eleonora; Valpreda, Alessandra; Sivera, Piera; Montaruli, Barbara; Porreca, Annamaria; Massaia, Massimo; Bruno, Benedetto; Borchiellini, Alessandra
Advances in biology of multiple myeloma: cell kinetics, molecular biology and immunology. 1989 PILERI A ;FERRERO D ;MASSAIA M ;DIANZANI U ;BOCCADORO M
Altered expression of growth-regulated protoncogenes in human malignant plasma cells. 1989 Palumbo A; Pileri A; Dianzani U; Massaia M; Boccadoro M; Calabretta B
Altered expression of growth-regulated protooncogenes in human malignant plasma cells 1989 A. PALUMBO; A. PILERI; U. DIANZANI; M. MASSAIA; B. CALABRETTA; M. BOCCADORO
Aminobisphosphonates, statins and the mevalonate pathway: a cross-road to fine-tune the activation of NK and Vγ9Vδ2 T cells. 2012 Massaia M.
Amplification of T cell activation induced by CD73 (ecto-5' nucleotidase) engagement. 1991 MASSAIA M; ATTISANO C; REDOGLIA V; BIANCHI A; THOMPSON LF; DIANZANI U; PILERI A
An Update of a Comparison of Nonmyeloablative Allografting with Autografting for Newly Diagnosed Myeloma. 2007 B. Bruno; R. Sorasio; F. Patriarca; N. Mordini; B. Allione; F. Carnevale-Schianca; L. Giaccone; M. Rotta; P. Omedè; I. Baldi; S. Bringhen; M. Massaia; M. Aglietta; A. Levis; D. Mattei; R. Fanin; A. Palumbo; R. Storb; G. Ciccone; and Mario Boccadoro
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma 2015 Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M.
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. 2013 Chillemi A;Zaccarello G;Quarona V;Ferracin M;Ghimenti C;Massaia M;Horenstein AL;Malavasi F
Anticancer innovative therapy: Highlights from the ninth annual meeting 2020 Volpari T.; De Santis F.; Bracken A.P.; Pupa S.M.; Buschbeck M.; Wegner A.; Di Cosimo S.; Lisanti M.P.; Dotti G.; Massaia M.; Pruneri G.; Anichini A.; Fortunato O.; De Braud F.; Del Vecchio M.; Di Nicola M.
Antitumor vaccination: where we stand. 2000 BOCCHIA M ;BRONTE V ;COLOMBO MP ;DE VINCENTIIS A ;DI NICOLA M ;FORNI G ;LANATA L ;LEMOLI RM ;MASSAIA M ;RONDELLI D ;ZANON P ;TURA S
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells 2017 Castella, Barbara; Kopecka, Joanna; Sciancalepore, Patrizia; Mandili, Giorgia; Foglietta, Myriam; Mitro, Nico; Caruso, Donatella; Novelli, Francesco; Riganti, Chiara; Massaia, Massimo